VISION MEDICINES

Vision Medicines has a promising drug candidate to treat Stargardt disease, a rare genetic retinal degenerative disease, and other rare diseases caused by inborn errors of aldehyde metabolism. Vision Medicines has recruited a world-class scientific advisory board that includes leading scientists and clinicians specializing in retinal biology and genetics.